Improve the dupilumab therapy evaluation with dermoscopy and high-frequency ultrasound in moderate-to-severe atopic dermatitis.
Zhaorui LiuZiHan NiuDing-Ding ZhangJie LiuChenyang ZhaoPublished in: Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) (2023)
Dermoscopy and HFUS were able to reveal deeper inflammation response than clinical scores in AD and can be an effective method to evaluate and monitor clinical improvement during dupilumab treatment for AD patients. The preliminary value of imaging methods for predicting the treatment endpoint of dupilumab remains to be verified.
Keyphrases
- peritoneal dialysis
- end stage renal disease
- atopic dermatitis
- high frequency
- transcranial magnetic stimulation
- magnetic resonance imaging
- oxidative stress
- high resolution
- gene expression
- chronic kidney disease
- early onset
- high intensity
- combination therapy
- genome wide
- computed tomography
- newly diagnosed
- mass spectrometry
- single cell
- mesenchymal stem cells
- patient reported outcomes
- fluorescence imaging
- patient reported